Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan

• Published in: BMC infectious diseases Vol. 20; no. 1; pp. 1 - 7
• Main Authors: Ahmad, Tauseef, Jadoon, Muhammad Ayub, Khan, Muhammad, Khan, Muhammad Mumtaz, Hussain, Akbar, Musa, Taha Hussein, Waqar, Muhammad, Ejeta, Eyasu, Karami, Manoochehr, Alene, Kefyalew Addis, Jin, Hui
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 01.07.2020; BioMed Central; BMC
• Subjects: Age; Analysis; Care and treatment; Clinical outcomes; Communicable diseases; Confidence intervals; Hospitals; Infectious diseases; Laboratories; Low income groups; Medical research; Medical treatment; Microscopy; Pakistan; Patient outcomes; Patients; Regression analysis; Regression models; Statistical analysis; Studies; Success; Treatment outcome; Tuberculosis; Pakistan; Ethiopia
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-020-05184-3

Globally, tuberculosis (TB) remains the leading cause of death from a single infectious disease. TB treatment outcome is an important indicator for the effectiveness of a national TB control program. This study aimed to assess treatment outcomes of TB patients and its determinants in Batkhela, Khyber Pakhtunkhwa, Pakistan. A retrospective cohort study was designed using all TB patients who were enrolled at District Head Quarter (DHQ) Hospital Batkhela, Pakistan, from January 2011 to December 2014. A binary logistic regression models were used to identify factors associated with successful TB treatment outcomes defined as the sum of cure and completed treatment. A total of 515 TB patients were registered, of which 237 (46%) were males and 278 (53.98%) females. Of all patients, 234 (45.44%) were cured and 210 (40.77%) completed treatment. The overall treatment success rate was 444 (86.21%). Age 0-20 years (adjusted odds ratio, AOR = 3.47; 95% confidence interval, CI) = 1.54-7.81; P = 0.003), smear-positive pulmonary TB (AOR) = 3.58; 95% CI = 1.89-6.78; P = < 0.001), treatment category (AOR = 4.71; 95% CI = 1.17-18.97; P = 0.029), and year of enrollment 2012 (AOR = 6.26; 95% CI = 2.52-15.59; P = < 0.001) were significantly associated with successful treatment outcome. The overall treatment success rate is satisfactory but still need to be improved to achieve the international targeted treatment outcome. Type of TB, age, treatment category, and year of enrollment were significantly associated with successful treatment outcomes.